ANKH Knockout HT29 Polyclonal Cells consist of a heterogeneous population of HT29 human colorectal adenocarcinoma cells engineered via CRISPR/Cas9-mediated disruption of the ANKH gene. This polyclonal knockout model carries diverse editing outcomes, collectively resulting in loss of ANKH-encoded inorganic pyrophosphate (PPi) transporter function while preserving population-level heterogeneity and minimizing clonal selection bias. The gene disruption was introduced through CRISPR/Cas9 nuclease targeting, creating permanent loss-of-function modifications without the use of exogenous selection markers that could confound downstream phenotypic analyses.
HT29 is a human colorectal adenocarcinoma cell line originally isolated in 1964 from a primary tumor of a 44-year-old female Caucasian. The cells form adherent monolayers with characteristic epithelial morphology and express intestinal markers, including microvilli, making them a reliable intestinal epithelial model for colorectal cancer research. HT29 cells retain features of differentiated enterocytes and are widely employed to investigate oncogenic signaling, tumor biology, and therapeutic responses, supported by well-characterized genomic and transcriptomic profiles that facilitate integration with knockout phenotype data.
ANKH encodes a multipass transmembrane protein that functions as a pyrophosphate exporter, transporting intracellular PPi into the extracellular matrix where it potently inhibits hydroxyapatite crystal nucleation and growth, thereby directly regulating tissue mineralization. ANKH activity is positively controlled by upstream signaling factors including parathyroid hormone (PTH), WNT3A, TGF-??1, IL-1??, and the transcription factor MEF2C. Downstream, ANKH-mediated PPi export influences expression of key mineralization regulators such as RUNX2, SP7, ALPL (tissue-nonspecific alkaline phosphatase, TNAP), and SPP1 (osteopontin), and modulates the MAPK/ERK pathway. ANKH physically interacts with ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1), which generates PPi from ATP, and forms homodimers, while TNAP hydrolyzes PPi, establishing a dynamic regulatory axis that fine-tunes local PPi concentration and mineralization levels.
Within the HT29 colorectal adenocarcinoma background, ANKH knockout provides a specialized platform for dissecting the role of pyrophosphate metabolism in gastrointestinal tumor biology. Though ANKH is primarily characterized in bone and cartilage, emerging evidence links ectopic calcification and altered mineralization regulators to tumor microenvironment stiffening, metastasis, and cancer cell signaling. HT29 cells inherently express components of the WNT signaling pathway, a pivotal oncogenic driver in colorectal cancer that also regulates ANKH expression. Thus, ANKH loss-of-function enables investigation of crosstalk between WNT/??-catenin signaling, pyrophosphate handling, and tumor cell behaviors such as migration and invasion, while the polyclonal population maintains the heterogeneity intrinsic to tumor cells, offering a more realistic model than clonal isolates for functional studies.
Researchers can employ ANKH Knockout HT29 Polyclonal Cells in a diverse panel of assays to elucidate pyrophosphate-dependent mechanisms in cancer. Representative applications include quantifying extracellular PPi using fluorometric or enzymatic assays, assessing mineralization potential via Alizarin Red S staining after osteogenic induction, and measuring alkaline phosphatase activity to evaluate TNAP-mediated counter-regulation. Co-immunoprecipitation with ENPP1 and western blotting confirm protein interactions and expression changes, while RNA-seq provides unbiased transcriptomic profiling of pathway alterations. Migration and invasion assays reveal phenotypic consequences linked to matrix mineralization and tumor progression. These cells are also suitable for drug screening targeting calcium pyrophosphate deposition disease, modeling craniometaphyseal dysplasia-associated signaling defects, and functional genomics of mineralization inhibitors. For further information or custom configurations, please contact Ascent Research.
